The life sciences industry appears poised for significant transformation in 2025, driven by digital advancements and scientific innovations. Despite competitive pressures and business volatility, most global life sciences executives are optimistic about the future.

2024年4月25日 · What Is the Life Science Industry? The life science industry addresses critical global health and environmental challenges through rapid technological advancements and innovation, particularly in biotechnology, pharmaceuticals, and medical devices.

2025年1月9日 · With 2025 here, and in the midst of life sciences’ technological renaissance, this selection of multimedia content provides a pharma market overview in the US and Europe, including standout...

2025年2月6日 · U.S life sciences employment hit a record high in late 2024 and more job growth is expected in 2025. The life sciences industry remains in a period of unprecedented innovation and discovery. FDA novel drug approvals in 2024 were the sixth highest annual total on record.

Cushman & Wakefield’s 2024 life sciences market report covers national trends and dive deep into top global life sciences markets, for an in-depth look at this quickly changing industry.

2023年4月3日 · After record years in 2020 and 2021, growth of the U.S. life sciences industry has returned to a more normal pace in 2023, although demand for lab/R&D space remains well above pre-pandemic levels. Life sciences employment reached a record high at the start of 2023, although the rate of growth slowed.

Our 2025 outlook focuses on pragmatic opportunities to address current barriers in the life sciences sector—realistic solutions that can enhance research capabilities, streamline regulatory processes, and foster innovation for better health outcomes and experiences.

2024年5月31日 · In our 2024 Global Life Sciences Sector Outlook report, we emphasize on these key trends such as increasing pricing pressures, geopolitical environment, changes in US regulations, and the acceleration of Generative AI (GenAI) adoption to expedite drug discovery, cost reduction and revenue uplift.

The life sciences industry has made major breakthroughs in precision medicine, which comprises treatments tailored to individuals’ unique genetic profiles and, in some cases, engineers a therapy from a patient’s own cells. Clinicians gain insight into …

Our 2020 global life sciences outlook takes an in-depth look into why life sciences companies should consider creating a holistic patient experience. We are moving closer to the promise of true precision medicine and a future of health where we learn from every radically interoperable data point in the context of every patient.